Loading clinical trials...
Loading clinical trials...
Walnut as a First Food During Complementary Feeding on Gut Microbiota and Immunity Development in Breastfed Infants
The objective is to investigate the effect of walnuts on gut microbiota, inflammatory markers, atopic dermatitis status, and indices of allergy outcomes in breastfed infants during early complementary feeding. The three primary aims include: Aim 1: Evaluate the effect of walnut consumption on gut microbiota structure and function, inflammation, atopic dermatitis, and allergy outcomes. Aim 2: Evaluate the impact of walnut consumption on infant growth trajectories and risk of overweight. Aim 3 (exploratory): Identify walnut-specific food signatures that are associated with gut microbiota and immunity biomarkers using a novel nutri-metabolomics technique.
Some details are intentionally left to out to preserve the scientific integrity of the study, and they will be included in the record after the study is completed.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Food Science and Human Nutrition Clinical Research Laboratory
Fort Collins, Colorado, United States
Start Date
May 18, 2025
Primary Completion Date
December 1, 2027
Completion Date
December 31, 2027
Last Updated
July 23, 2025
90
ESTIMATED participants
Infant walnut intake
OTHER
Lead Sponsor
Colorado State University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07287345